Healthcare
LENZ
LENZ Therapeutics, Inc.
$5.11+6.24%
Add to Watchlist
Loading chart...
About LENZ Therapeutics, Inc.
LENZ Therapeutics develops pharmaceutical treatments for vision problems. The company's main focus is presbyopia, which is the age-related difficulty in focusing on nearby objects that most people experience starting in their 40s. Its product candidates include VIZZ and LNZ101, both designed to treat presbyopia in adults. The company is based in California and was founded in 2013.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore